10.1038/s41408-023-00813-x - CD19/CD22 bispecific CAR-T cells for ...

This document has been corrected

CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

10.1038/s41408-023-00813-x

Published Online: 2023-03-24

Journal: Blood Cancer Journal•Publisher: Springer Science and Business Media LLC

Authors: Baoxia Dong•Chongmei Huang•Fang Xiang•Haopeng Wang•Huiying Qiu•Jiahua Niu•Jun Yang•Kun Zhou•Lin Zhu•Liping Wan•Xianmin Song•Xuedong Sun•Xueying Ding•Yin Tong•Yu Cai•Yuan Lu

This document has been corrected

CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

10.1038/s41408-023-00813-x

Published Online: 2023-03-24

Journal: Blood Cancer Journal

NOW

2023-04-13•Correction

Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

10.1038/s41408-023-00825-7

* information provided by CrossRef

2023-04-13•Correction

10.1038/s41408-023-00825-7

* information provided by CrossRef

2023-03-24•Published

2023-04-13•Correction

Correction: CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

10.1038/s41408-023-00825-7

* information provided by CrossRef

This document has been corrected

CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

10.1038/s41408-023-00813-x

Published Online: 2023-03-24

Journal: Blood Cancer Journal•Publisher: Springer Science and Business Media LLC